Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stimulating T cell responses against patient-derived breast cancer cells with neoantigen peptide-loaded peripheral blood mononuclear cells

13 Feb 2024

Abstract excerpt

Abstract Breast cancer stands as a formidable global health challenge for women. While neoantigens exhibit efficacy in activating T cells specific to cancer and instigating anti-tumor immune responses, the accuracy of neoantigen prediction remains suboptimal. In this study, we identified neoantigens from the patient-derived breast cancer cells, PC-B-142CA and PC-B-148CA cells, utilizing whole-genome and RNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to CAR-T cell therapy research
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38349410
DOI: 10.1007/s00262-024-03627-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stimulating T cell responses against patient-derived breast cancer cells with neoantigen peptide-loaded peripheral blood mononuclear cellsPMID 38349410Read ↗

Neoantigens elicit T cell responses in breast cancerSemantic proximity Read ↗

Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity.Semantic proximity Read ↗

Neoantigens elicit T cell responses in breast cancerSemantic proximity Read ↗

Novel pipeline of high-frequency neoantigens heathy donor-based validation in breast cancerSemantic proximity Read ↗

HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancerSemantic proximity Read ↗

Neoantigen DNA vaccines are safe, feasible, and capable of inducing neoantigen-specific immune responses in patients with triple negative breast cancerSemantic proximity Read ↗

<i>In vitro</i> validation of neoantigen prediction algorithm for developing personalized cancer vaccine therapySemantic proximity Read ↗

Immunogenic mutanome of breast cancer: Advances, challenges and future directions in neoantigen-based immunotherapy.Semantic proximity Read ↗

A Comprehensive Survey of Genomic Mutations in Breast Cancer Reveals Recurrent Neoantigens as Potential Therapeutic TargetsSemantic proximity Read ↗

Transcriptomics and mutational analysis to screen immunogenic neoantigen peptides and Patient stratification based on immune subtypes for TNBCSemantic proximity Read ↗

A Comprehensive Survey of Genomic Mutations in Breast Cancer Reveals Recurrent Neoantigens as Potential Therapeutic TargetsSemantic proximity Read ↗

Exploring the Neoantigen burden in Breast Carcinoma PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.